How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients with Histologically Confirmed Nodal Metastases: Results of a Prospective Study

BACKGROUND: In breast cancer patients with nodal metastases at presentation, false-negative rates <10% have been demonstrated for sentinel node biopsy (SLNB) after neoadjuvant chemotherapy (NAC) when ≥3 negative sentinel nodes (SLNs) are retrieved, but the frequency with which axillary dissection...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Surg Oncol
Asıl Yazarlar: Mamtani, Anita, Barrio, Andrea V., King, Tari A., Van Zee, Kimberly J., Plitas, George, Pilewskie, Melissa, El-Tamer, Mahmoud, Gemignani, Mary L., Heerdt, Alexandra S., Sclafani, Lisa M., Sacchini, Virgilio, Cody, Hiram S., Patil, Sujata, Morrow, Monica
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070651/
https://ncbi.nlm.nih.gov/pubmed/27160528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5246-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller